2024-04-02 19:00:11 ET
Image source: The Motley Fool.
Ocugen (NASDAQ: OCGN)
Q4 2023 Earnings Call
Apr 02, 2024 , 8:30 a.m. ET
Operator
For further details see:
Ocugen (OCGN) Q4 2023 Earnings Call Transcript2024-04-02 19:00:11 ET
Image source: The Motley Fool.
Ocugen (NASDAQ: OCGN)
Q4 2023 Earnings Call
Apr 02, 2024 , 8:30 a.m. ET
Operator
For further details see:
Ocugen (OCGN) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
• Established Medium Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial • DSMB Determination to Proceed with High Dose Cohort Dosing MALVERN, Pa., June 21, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a bi...
MALVERN, Pa., June 20, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the first patient h...